RecruitingNCT06775821

Epidemiology of Abdominal Aortic Aneurysm With Concomitant Primary Lung Cancer


Sponsor

First Affiliated Hospital of Kunming Medical University

Enrollment

2,000 participants

Start Date

Oct 1, 2022

Study Type

OBSERVATIONAL

Conditions

Summary

Retrospective clinical case studies in recent years have shown that most cases of lung cancer and abdominal aortic aneurysm (AAA) are detected at the same time and that there is a wide variation in the prevalence of AAA in patients with primary lung cancer reported in the literature, with some papers suggesting as high as 11%, suggesting that there may be a relationship between the prevalence of the two diseases. However, its exact incidence and mechanism are unknown. Accurate prevention of AAA in patients with primary lung cancer requires more in-depth studies. To solve the above problems, a multi-center prospective epidemiological investigation and mechanism study on the association of AAA in primary lung cancer combined has become particularly urgent. The results of the study will be of great significance for the follow-up treatment and prognosis of lung cancer patients as well as the improvement of long-term survival rate of lung cancer patients, and will also provide scientific basis and clinical guidance for the screening and prevention of AAA in lung cancer patients.


Eligibility

Min Age: 20 YearsMax Age: 90 Years

Inclusion Criteria1

  • Patients diagnosed with primary lung cancer through clinical or pathological examination

Exclusion Criteria1

  • Patients diagnosed with primary lung cancer who refuse to undergo abdominal aortic imaging screening.

Interventions

DEVICEUltrasound or CT of the abdominal aorta

Patient underwent ultrasound or CT of the abdominal aorta


Locations(2)

The First Affiliated Hospital of Kunming Medical University

Kunming, Yunnan, China

The Third Affiliated Hospital of Kunming Medical University

Kunming, Yunnan, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06775821


Related Trials